Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Cdk10, a Cdc2-related kinase, associates with the Ets2 transcription factor and modulates its transactivation activity

Abstract

Cdk10 is a Cdc2-related kinase that may play a role in regulating the G2/M phase of the cell cycle. However little is known about the proteins that interact with this putative kinase and contribute to its function in the cell. We report in this study that Cdk10 interacts with the N-terminus of the Ets2 transcription factor, which contains the highly conserved Pointed domain and transactivation domain. The Pointed domain has been implicated in protein–protein interactions and we find that Ets2 requires an intact Pointed domain to bind Cdk10. The Pointed domain of Ets1 is highly similar to Ets2, however Cdk10 does not recognize Ets1 in a two-hybrid assay thereby demonstrating significant binding specificity on the part of Cdk10. We find that Cdk10 binds full length Ets2 in vitro and in vivo and inhibits Ets2 transactivation in mammalian cells.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Basuyaux JP, Ferreira E, Stehelin D, Buttice G . 1997 J. Biol. Chem. 272: 26188–26195

  • Brambilla R, Draetta G . 1994 Oncogene 9: 3037–3041

  • Breeden L, Nasmyth K . 1987 Cell 48: 389–397

  • Carroll M, Tomasson MH, Barker GF, Golub TR, Gilliland DG . 1996 Proc. Natl. Acad. Sci. USA 93: 14845–14850

  • Chumakov AM, Chen DL, Chumakova EA, Koeffler HP . 1993 J. Virol. 67: 2421–2425

  • Claudio PP, Howard CM, Baldi A, De Luca A, Fu Y, Condorelli G, Sun Y, Colburn N, Calabretta B, Giordano A . 1994 Cancer Res. 54: 5556–5560

  • Dohrmann PR, Voth WP, Stillman DJ . 1996 Mol. Cell. Biol. 16: 1746–1758

  • Golemis EA, Serebriiskii J, Gyuris J, Brent R . 1997 Current Protocols in Molecular Biology John Wiley & Sons: NY pp 20.1.1–20.1.35

    Google Scholar 

  • Grana X, Claudio PP, De Luca A, Sang N, Giordano A . 1994 Oncogene 9: 2097–2103

  • Graves BJ, Petersen JM . 1998 Adv. Cancer Res. 75: 1–55

  • Gyuris J, Golemis E, Chertkov H, Brent R . 1993 Cell 75: 791–803

  • Herskowitz I . 1987 Nature 329: 219–222

  • Jayaraman G, Srinivas R, Duggan C, Ferreira E, Swaminathan S, Somasundaram K, Williams J, Hauser C, Kurkinen M, Dhar R, Weitzman S, Buttice G, Thimmapaya B . 1999 J. Biol. Chem. 274: 17342–17352

  • Jousset C, Carron C, Boureux A, Quang CT, Oury C, Dusanter-Fourt I, Charon M, Levin J, Bernard O, Ghysdael J . 1997 EMBO J. 16: 69–82

  • Li S, MacLachlan TK, De Luca A, Claudio PP, Condorelli G, Giordano A . 1995 Cancer Res. 55: 3992–3995

  • Liu AY, Corey E, Vessella RL, Lange PH, True LD, Huang GM, Nelson PS, Hood L . 1997 Prostate 30: 145–153

  • MacLachlan TK, Sang N, De Luca A, Puri PL, Levrero M, Giordano A . 1998 J. Cell. Biochem. 71: 467–478

  • MacLachlan TK, Sang N, Giordano A . 1995 Crit. Rev. Eukaryot. Gene. Expr. 5: 127–156

  • Morgan DO . 1997 Annu. Rev. Cell. Dev. Biol. 13: 261–291

  • Puri PL, Wu Z, Zhang P, Wood LD, Bhakta KS, Han J, Feramisco JR, Karin M, Wang JY . 2000 Genes. Dev. 14: 574–584

  • Schneikert J, Lutz Y, Wasylyk B . 1992 Oncogene 7: 249–256

  • Sementchenko VI, Schweinfest CW, Papas TS, Watson DK . 1998 Oncogene 17: 2883–2888

  • Seth A, Watson DK, Blair DG, Papas TS . 1989 Proc. Natl. Acad. Sci. USA 86: 7833–7837

  • Sherman F . 1991 Methods Enzymol. 194: 3–21

  • Simpson S, Woodworth CD, DiPaolo JA . 1997 Oncogene 14: 2149–2157

  • Slupsky CM, Gentile LN, Donaldson LW, Mackereth CD, Seidel JJ, Graves BJ, McIntosh LP . 1998 Proc. Natl. Acad. Sci. USA 95: 12129–12134

  • van den Heuvel S, Harlow E . 1993 Science 262: 2050–2054

  • Watson DK, McWilliams MJ, Lapis P, Lautenberger JA, Schweinfest CW, Papas TS . 1988 Proc. Natl. Acad. Sci. USA 85: 7862–7866

  • Watson MA, Buckholz R, Weiner MP . 1996 Biotechniques 21: 255–259

  • Wen SC, Ku DH, De Luca A, Claudio PP, Giordano A, Calabretta B . 1995 Exp. Cell. Res. 217: 8–14

  • Yang BS, Hauser CA, Henkel G, Colman MS, Van Beveren C, Stacey KJ, Hume DA, Maki RA, Ostrowski MC . 1996 Mol. Cell. Biol. 16: 538–547

Download references

Acknowledgements

We are grateful to Alexi Chumakov and Dennis Watson for plasmids and Erica Golemis for two-hybrid reagents and advice. We wish to thank Barbara Graves and the members of the Giordano lab for helpful discussions. We especially thank Peter Stiegler and Robert Mecklenburg for their support and encouragement. M Kasten was supported by NCI training grant 5 T32 CA 09137. This work was supported by a grant from the National Institutes of Health awarded to A Giordano.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kasten, M., Giordano, A. Cdk10, a Cdc2-related kinase, associates with the Ets2 transcription factor and modulates its transactivation activity. Oncogene 20, 1832–1838 (2001). https://doi.org/10.1038/sj.onc.1204295

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204295

Keywords

This article is cited by

Search

Quick links